These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8701083)

  • 21. Hypothalamic targets for growth hormone secretagogues.
    Robinson IC
    Acta Paediatr Suppl; 1997 Nov; 423():88-91. PubMed ID: 9401551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway.
    Bailey AR; von Engelhardt N; Leng G; Smith RG; Dickson SL
    J Neuroendocrinol; 2000 Mar; 12(3):191-7. PubMed ID: 10718914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone-releasing hormone and morphine attenuate growth hormone secretagogue-induced activation of the arcuate nucleus in the male rat.
    Bailey AR; Honda K; Smith RG; Leng G
    Neuroendocrinology; 1999 Aug; 70(2):101-6. PubMed ID: 10461024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone releasing substances: types and their receptors.
    Smith RG; Palyha OC; Feighner SD; Tan CP; McKee KK; Hreniuk DL; Yang L; Morriello G; Nargund R; Patchett AA; Howard AD
    Horm Res; 1999; 51 Suppl 3():1-8. PubMed ID: 10592437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
    Patchett AA; Nargund RP; Tata JR; Chen MH; Barakat KJ; Johnston DB; Cheng K; Chan WW; Butler B; Hickey G
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7001-5. PubMed ID: 7624358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a new G-protein-linked receptor for growth hormone secretagogues.
    Pong SS; Chaung LY; Dean DC; Nargund RP; Patchett AA; Smith RG
    Mol Endocrinol; 1996 Jan; 10(1):57-61. PubMed ID: 8838145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endocrine regulation network of growth hormone synthesis and secretion in fish: emphasis on the signal integration in somatotropes.
    Li W; Lin H
    Sci China Life Sci; 2010 Apr; 53(4):462-70. PubMed ID: 20596912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    Muccioli G; Ghè C; Ghigo MC; Papotti M; Arvat E; Boghen MF; Nilsson MH; Deghenghi R; Ong H; Ghigo E
    J Endocrinol; 1998 Apr; 157(1):99-106. PubMed ID: 9614363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles.
    Hickey GJ; Jacks TM; Schleim KD; Frazier E; Chen HY; Krupa D; Feeney W; Nargund RP; Patchett AA; Smith RG
    J Endocrinol; 1997 Feb; 152(2):183-92. PubMed ID: 9071975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine is an agonist of the growth hormone secretagogue receptor.
    Tullin S; Hansen BS; Ankersen M; Møller J; Von Cappelen KA; Thim L
    Endocrinology; 2000 Sep; 141(9):3397-402. PubMed ID: 10965912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of growth hormone secretagogues.
    Smith RG
    Endocr Rev; 2005 May; 26(3):346-60. PubMed ID: 15814848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.
    Bailey AR; Smith RG; Leng G
    J Neuroendocrinol; 1998 Feb; 10(2):111-8. PubMed ID: 9535057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genesis of episodic growth hormone secretion.
    Tannenbaum GS
    J Pediatr Endocrinol; 1993; 6(3-4):273-82. PubMed ID: 7920994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Orphan Receptor Involved in Pulsatile Growth Hormone Release.
    Smith RG; Feighner S; Prendergast K; Guan X; Howard A
    Trends Endocrinol Metab; 1999 May; 10(4):128-135. PubMed ID: 10322406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptidomimetic regulation of growth hormone secretion.
    Smith RG; Van der Ploeg LH; Howard AD; Feighner SD; Cheng K; Hickey GJ; Wyvratt MJ; Fisher MH; Nargund RP; Patchett AA
    Endocr Rev; 1997 Oct; 18(5):621-45. PubMed ID: 9331545
    [No Abstract]   [Full Text] [Related]  

  • 36. 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years.
    Murray PG; Higham CE; Clayton PE
    J Endocrinol; 2015 Aug; 226(2):T123-40. PubMed ID: 26040485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor.
    Dean DC; Nargund RP; Pong SS; Chaung LY; Griffin P; Melillo DG; Ellsworth RL; Van der Ploeg LH; Patchett AA; Smith RG
    J Med Chem; 1996 Apr; 39(9):1767-70. PubMed ID: 8627599
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypothalamic regulation of the secretion of the growth hormone].
    Popa M
    Stud Cercet Endocrinol; 1971; 22(6):413-25. PubMed ID: 5135417
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth hormone secretagogues: mechanism of action and use in aging.
    Fuh VL; Bach MA
    Growth Horm IGF Res; 1998 Feb; 8(1):13-20. PubMed ID: 10990440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.
    Hansen TK; Ankersen M; Raun K; Hansen BS
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1915-8. PubMed ID: 11459660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.